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Few areas of medicine have posed a greater challenge to
theadoptionofapopulation-levelorepidemiologicapproach
than psychiatry. From the privacy required for many thera-
peutic methods to the complexity and seeming individuality
of each patient, the history and nature of mental illness has
often appeared antithetical to the epidemiologic method. At
thesametime,theprevalence,severity,andoverallburdenof
morbidity and mortality represented by mental disorders re-
ﬂects an urgent global public health concern ripe for the
application of epidemiology. The gains realized through ad-
vances in psychiatric epidemiology over the past decade, the
resulting potential of an empirically informed, population-
oriented approach to reducing the global burden of mental
illness,andmajormethodologicalchallengesfortheﬁeldare
highlighted in the current issue of Epidemiologic Reviews,
which accompanies this issue of the Journal.
It has been over a decade since the last issue of Epidemi-
ologic Reviews dedicated to psychiatric epidemiology ap-
peared in 1995. Despite impressive advances in genetics,
neuroscience, brain imaging, and other technologies during
these past 13 years, the scope and magnitude of the problem
are no less demanding. High-quality epidemiologic inves-
tigations in the United States and worldwide have yielded
quite consistent estimates of the prevalence of major mental
disorders. Data from the recent replication of the National
Comorbidity Survey, a representative sample of US adults,
suggest that an estimated 13 million American adults
(approximately 1 in 17) have a seriously debilitating mental
illness (1, 2).
The strikingly prominent place of mental disorders in the
total pattern of morbidity and mortality worldwide was
highlighted in the World Health Organization’s initial
Global Burden of Disease (3) report, a ﬁnding that has been
sustained in recent updates (4). According to World Health
Organization estimates for 2002, mental health disorders are
the leading cause of disability in the United States and
Canada, accounting for 25% of all years of life lost to dis-
ability and premature mortality (4). Worldwide, it is esti-
mated that mental disorders account for 12% of disability-
adjusted life years. In terms of mortality, suicide alone is the
11th leading cause of death in the United States, with ap-
proximately 30,000 deaths per year (5), and this is an issue
of concern worldwide as well. Estimating the costs associ-
ated with mental illness is challenging, but estimates sug-
gest annual treatment costs in the United States of $100
billion, with signiﬁcantly more for indirect costs; $193
billion per year is estimated for lost earnings alone (2).
While these ﬁndings reveal concrete developments in the
foundations of psychiatric epidemiology (standardized and
replicated nosology; high-quality prevalence estimates), ad-
vances in the identiﬁcation of risk factors, etiologic mech-
anisms, and preventive interventions have been more
modest. For instance, a 2004 literature review commis-
sioned by the National Institute of Mental Health revealed
that while there has been considerable growth in the number
of high-quality longitudinal studies with well-characterized
psychiatric outcomes, there is strikingly little consistency in
the coverage, measurement, and (therefore) replication of
potential risk factors across investigations (6). Clearly, con-
siderable ground remains to be covered in psychiatric epi-
demiology to move from statements of prevalence to
insights regarding disease etiology and prevention.
The forthcoming issue of Epidemiologic Reviews pro-
vides an informative summary of many of these strengths
and challenges in psychiatric epidemiology. The 10 articles
in the issue provide a succinct presentation of the many
contributions the ﬁeld brings to broadening the knowledge
base and investigating strategies for disease prevention
in the realm of mental illness. These include: 1) detailed
narrative reviews of the epidemiology of individual disor-
ders (schizophrenia (7), suicide (8), and Alzheimer’s dis-
ease (9)); 2) systematic reviews and meta-analyses of
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(place of residence/neighborhood attributes and risks of
both depression (10) and psychosis (11), working conditions
and depression (12), premorbid intelligence quotient and
psychosis (13)); 3) major ﬁndings and methodological ad-
vances regardingtheanalysisofco-occurringor‘‘comorbid’’
forms of psychopathology (14); 4) challenges and opportu-
nities in moving from observational studies to preventive
clinical trials (15); and 5) an overarching summary of the
prevalence, impairment, and cost associated with 11 major
mental disorders of adults (16).
One clear sign of encouragement from this body of work
is that the number of well-conducted prospective and cross-
sectionalpopulation-basedstudiesisconsiderableandgrow-
ing. On the basis of these studies, the authors in this special
issue have been able to not only summarize more accurately
the prevalence and incidence of major adult disorders but,
more interestingly, also discern meaningful variation in dis-
ease distributions that set the stage for new etiologic inves-
tigations. For example, Nock et al.’s review of global suicide
and suicidal behavior (8) concludes that ‘‘the signiﬁcant
cross-national variability...appears to reﬂect the true nature
of this behavior and is not due to variation in research meth-
ods’’ and proceeds to elaborate new methodological and
theoretical advances that are likely to yield new insight into
the origins of these behaviors. Similarly, McGrath et al. (7)
challenge the common perception that the incidence and
prevalence of schizophrenia are relatively even across re-
gions, and they highlight a number of potential risk factors
related to urbanicity, economic status, migrant status, and
latitude that might play an etiologic role and account for this
variation. Despite these positive advances, Eaton et al.’s
summary of the ‘‘global burden’’ associated with adult men-
taldisorders(16) providessuccinct guidance byhighlighting
a number of disorders for which basic incidence and preva-
lence data are sparse and how extremely limited are even the
most rudimentary data on disability, mortality, and costs.
With a focus on a range of potential etiologic factors
ranging from social conditions to speciﬁc polymorphisms,
psychiatric epidemiology has been and should continue to
be recognized as related to but distinct from other branches
of our discipline, most notably social epidemiology (17). At
the same time, the methodological and conceptual advance-
ments of social epidemiology have enhanced a long-stand-
ing tradition of inquiry into the impact of the broader social
environment on the genesis of mental illness. These cross-
fertilizations are elegantly displayed with thework of March
et al. (11) and Kim (12). Kim’s systematic review of 28
studies (12) supports a positive association between neigh-
borhood social disorder and depression and to a lesser extent
suggests protective effects for neighborhood socioeconomic
status. March et al. (11) observe positive associations be-
tween urbanicity, ethnic density, social isolation, and non-
affective (but not affective) psychoses. Both papers provide
a compelling impetus for new lines of inquiry and the pos-
sibility of community-level (rather than more traditional
individual-level) interventions for the prevention or minimi-
zationofthesehigh-burdendisorders.Finally,the contribution
by Cerda et al. (14) reminds us that while most investigators
consider single disease endpoints, co-occurrence or comor-
bidity both is common and greatly increases the burden on
patient and society. Their careful summary of ﬁndings from
58 articles documents the extent of comorbidity, summa-
rizes conceptual approaches that will be needed to account
for it, and makes valuable recommendations for the future
research that will be required to obtain new insight into the
pathways leading to such co-occurrence.
This special issue of Epidemiologic Reviews provides an
excellent summary of the ground covered and the road
ahead regarding the epidemiologic investigation and public
health strategies needed to reduce the prevalence, severity,
and impairment resulting from mental illness. It provides
high-quality, well-written summaries of large bodies of lit-
erature and sheds new light on both the limitations of stan-
dard epidemiologic approaches in this arena and valuable
future directions for the ﬁeld. Old-timers in the ﬁeld will
read it with a sense of appreciation for the advances we have
made, while newcomers will be energized and stimulated by
an awareness of the immediacy of the problem and the clear
avenues available for meaningful new discovery.
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